Overview

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata

Status:
Unknown status
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study aims to prospectively assess whether there is an interaction between genetic status in terms of 2C19 activity and residual platelet reactivity after clopidogrel intake in patients who underwent coronary stenting for elective, urgent or emergent intervention.
Phase:
Phase 4
Details
Lead Sponsor:
Università degli Studi di Ferrara
Treatments:
Clopidogrel
Dexlansoprazole
Lansoprazole
Proton Pump Inhibitors
Ticlopidine